↓ Skip to main content

OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley